Haleon PLC (GB:HLN) has released an update.
Haleon PLC has just announced a substantial purchase of 849,743 of its own shares for cancellation as part of its share buyback program initiated on August 1, 2024. Following the transaction, the company’s total registered share capital stands at 9,116,326,523 ordinary shares. This move by the global consumer health leader, known for brands such as Advil and Sensodyne, is a strategic effort to enhance shareholder value.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
